Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAIR: Paracetamol vs Ibuprofen for hsPDA
NCT04986839Phase 3Unknown
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Sep 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of acetaminophen in patent ductus arteriosus (PDA) (2 arms), sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Conversion of haemodynamically significant PDA (hsPDA) to non-hsPDA at 3 days. Status: unknown.
02
Drugs
acetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NCT04986839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04986839.